Other names: Flonase
Categories: Over the Counter Medication
Description:
Flonase (fluticasone propionate) is a nasal corticosteroid that helps reduce inflammation in the nasal passages and Eustachian tubes, making it an effective long-term treatment for Eustachian Tube Dysfunction (ETD) caused by allergies or chronic sinus inflammation. By decreasing swelling and mucus production, Flonase can improve drainage and help relieve ear fullness, pressure, and mild hearing loss associated with ETD. However, it does not provide immediate relief and may take several days to weeks for full effect.
Treatment For:
AI generated Summary: Based on the author's review, Fluticasone Propionate is an effective adjunct treatment for Eustachian Tube Dysfunction (ETD), particularly for chronic or allergy-related cases. While it may not provide immediate relief, consistent use of this medication can help reduce inflammation, nasal congestion, swelling, and mucus buildup over time, making it a valuable option when combined with other treatments.
As adjunct treatment that won’t provide immediate relief but effectively reduces inflammation and nasal congestion, helping improve Eustachian Tube Dysfunction (ETD) over time. Best used consistently, it works to decrease swelling and mucus buildup, making it a valuable option for chronic or allergy-related ETD when combined with other treatments.
ReplyThe information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright 2024 © By curbside, All Rights Reserved.
